Keros Therapeutics, Inc. earnings per share and revenue

KROS earnings per share for the last quarter are -1.21 USD whereas the estimation was -1.33 USD which accounts for 9.25% surprise. Företagets omsättning för samma period uppgår till 83.00 k USD trots den uppskattade siffran 0.00 USD. Estimated earnings per share for the next quarter are -1.25 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of KROS earnings per share and revenue dynamics.